Gene · 113451
Papers1,387
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,387
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Ion Mobility-Mass Spectrometry and Collision Induced Unfolding Reveal Linker-Payload Effects on Antibody-Drug Conjugate Higher-Order Structure and Stability. | Bioconjug Chem | 2026 | 42063277 | PubTator, text mining | PubMed |
| Evolving antibody-drug conjugates in breast cancer from precision delivery to tumor microenvironment reprogramming. | J Hematol Oncol | 2026 | 42036664 | PubTator, text mining | PubMed |
| High expression of the ADC target Claudin-6 associates with aggressive endometrial cancer and remains high in metastatic lesions. | BJC Rep | 2026 | 41986616 | PubTator, text mining | PubMed |
| Increased Agmatine Degradation in Children with Specific Learning Disorder. | Int J Mol Sci | 2026 | 41977269 | PubTator, text mining | PubMed |
| Immuno-cytotoxic convergence: integrating antibody‒drug conjugates and immunofusion proteins to overcome resistance in gastrointestinal cancers. | J Hematol Oncol | 2026 | 41947238 | PubTator, text mining | PubMed |
| ADC Target Profiling in NSCLC: Generalizable AI Separates TROP-2 and cMET Phenotypes. | Clin Cancer Res | 2026 | 41945491 | PubTator, text mining | PubMed |
| Drug resistance to antibody-drug conjugates: mechanisms, challenges, and perspectives. | Cancer Biol Med | 2026 | 41943470 | PubTator, text mining | PubMed |
| Chaperonin in health and disease. | Mol Biomed | 2026 | 41920440 | PubTator, text mining | PubMed |
| [Role of Receptor Tyrosine Kinase AXL in Cancer Targeted Therapy Drug Resistance]. | Zhongguo Fei Ai Za Zhi | 2026 | 41916916 | PubTator, text mining | PubMed |
| Elucidating the relationship between affinity and potency in the performance of therapeutic IgE. | Sci Rep | 2026 | 41912649 | PubTator, text mining | PubMed |
| Mesenteric and antimesenteric border subregionalization using MR enterography: advancing fibrosis evaluation in Crohn disease. | Eur Radiol Exp | 2026 | 41910829 | PubTator, text mining | PubMed |
| Clinical application and optimization strategies for antibody-drug conjugates in solid tumors. | J Int Med Res | 2026 | 41904967 | PubTator, text mining | PubMed |
| Antibody-drug conjugates in oncology: a clinically focused review for nursing practice. | Expert Rev Anticancer Ther | 2026 | 41902827 | PubTator, text mining | PubMed |
| RGX-019-MMAE inhibits leukemia progression by targeting MER proto-oncogene tyrosine kinase (MERTK) in acute myeloid leukemia. | J Exp Clin Cancer Res | 2026 | 41896977 | PubTator, text mining | PubMed |
| Developmental coordination disorder traits persistently affect physical activity and sedentary behavior in adults. | Sci Rep | 2026 | 41896568 | PubTator, text mining | PubMed |
| Linvoseltamab versus real-world International Myeloma Working Group standard-of-care in triple-class exposed relapsed/refractory multiple myeloma. | Blood Cancer J | 2026 | 41881954 | PubTator, text mining | PubMed |
| Dysregulation of SIRT1, polyamines and miRNA editing in cancer and aging. | Amino Acids | 2026 | 41863647 | PubTator, text mining | PubMed |
| The future of urothelial carcinoma: a 2024-2025 update of early-phase trials of novel therapeutic agents. | Curr Opin Urol | 2026 | 41861349 | PubTator, text mining | PubMed |
| Diagnostic value of 3D arterial spin labeling plus diffusion-weighted imaging for transient ischemic attack and short-term stroke prognosis: A retrospective cohort study. | Medicine (Baltimore) | 2026 | 41861212 | PubTator, text mining | PubMed |
| Time and Motion Analysis of Controlled Substance Disposals: A Study of Workflows at a Single Center using Automated Dispensing Cabinets. | Anesthesiol Open | 2026 | 41858840 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/113451/papers?page=3